---
schema_version: "secwatch.filing_event.v1"
accession: "0001157523-21-001255"
form_type: "8-K"
ticker: "USNA"
cik: "0000896264"
company_name: "USANA HEALTH SCIENCES INC"
filed_at: "2021-10-26T23:59:59+00:00"
generated_at: "2026-06-28T18:16:46.817628+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# USANA Q3 net sales $274.4M, EPS $1.36; reiterates FY2021 outlook

## Summary
- Net sales $274.4M (-8% YoY); diluted EPS $1.36 (-6% YoY).
- Active customers 576,000 (-11% YoY); Greater China active customers -13% YoY.
- Reiterates FY2021 net sales $1.18-$1.20B, EPS $5.80-$6.00; expects ~$130M free cash flow.
- Cash $249M, no debt; repurchased 523k shares for $50M, $137M remaining under authorization.
- Supply chain disruptions and inflationary pressures continue; product launches delayed to 2022.

## SEC filing metadata
- accession: 0001157523-21-001255
- form_type: 8-K
- ticker: USNA
- cik: 0000896264
- company_name: USANA HEALTH SCIENCES INC
- filed_at: 2021-10-26T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/896264/000115752321001255/0001157523-21-001255-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/896264/000115752321001255/a52516018.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001157523-21-001255
- JSON: https://secwatch.observer/filing/0001157523-21-001255.json
- Plain text: https://secwatch.observer/filing/0001157523-21-001255.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.